Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma.
Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):422-432. doi: 10.1016/j.ijrobp.2022.07.001. Epub 2022 Jul 16.
Int J Radiat Oncol Biol Phys. 2022.
PMID: 35850363
Free article.
Clinical Trial.
Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence.
Borkowska AM, Szumera-Ciećkiewicz A, Szostakowski B, Pieńkowski A, Rutkowski PL.
Borkowska AM, et al.
Cancers (Basel). 2022 May 4;14(9):2290. doi: 10.3390/cancers14092290.
Cancers (Basel). 2022.
PMID: 35565419
Free PMC article.
Review.
Item in Clipboard
Clinical Significance of Tumor Microenvironment in Acral Melanoma: A Large Single-Institution Study of Caucasians.
Borkowska AM, Szumera-Ciećkiewicz A, Chraszczewska M, Sokół K, Goryń T, Rutkowski PŁ.
Borkowska AM, et al.
J Clin Med. 2021 Apr 1;10(7):1452. doi: 10.3390/jcm10071452.
J Clin Med. 2021.
PMID: 33916279
Free PMC article.
Item in Clipboard
Clinicopathological Features and Prognostic Factors of Primary Acral Melanomas in Caucasians.
Borkowska AM, Szumera-Ciećkiewicz A, Spałek MJ, Teterycz P, Czarnecka AM, Rutkowski PŁ.
Borkowska AM, et al. Among authors: rutkowski pl.
J Clin Med. 2020 Sep 16;9(9):2996. doi: 10.3390/jcm9092996.
J Clin Med. 2020.
PMID: 32948014
Free PMC article.
Item in Clipboard
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial.
Bonvalot S, Rutkowski PL, Thariat J, Carrère S, Ducassou A, Sunyach MP, Agoston P, Hong A, Mervoyer A, Rastrelli M, Moreno V, Li RK, Tiangco B, Herraez AC, Gronchi A, Mangel L, Sy-Ortin T, Hohenberger P, de Baère T, Le Cesne A, Helfre S, Saada-Bouzid E, Borkowska A, Anghel R, Co A, Gebhart M, Kantor G, Montero A, Loong HH, Vergés R, Lapeire L, Dema S, Kacso G, Austen L, Moureau-Zabotto L, Servois V, Wardelmann E, Terrier P, Lazar AJ, Bovée JVMG, Le Péchoux C, Papai Z.
Bonvalot S, et al. Among authors: rutkowski pl.
Lancet Oncol. 2019 Aug;20(8):1148-1159. doi: 10.1016/S1470-2045(19)30326-2. Epub 2019 Jul 8.
Lancet Oncol. 2019.
PMID: 31296491
Clinical Trial.
Item in Clipboard
Management of the "Other" retroperitoneal sarcomas.
Rutkowski PL, Mullen JT.
Rutkowski PL, et al.
J Surg Oncol. 2018 Jan;117(1):79-86. doi: 10.1002/jso.24893. Epub 2017 Nov 11.
J Surg Oncol. 2018.
PMID: 29127695
Review.
Item in Clipboard
Cite
Cite